Shu Sahara

1.1k total citations
45 papers, 881 citations indexed

About

Shu Sahara is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shu Sahara has authored 45 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 20 papers in Gastroenterology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shu Sahara's work include Helicobacter pylori-related gastroenterology studies (33 papers), Gastroesophageal reflux and treatments (17 papers) and Gastric Cancer Management and Outcomes (10 papers). Shu Sahara is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (33 papers), Gastroesophageal reflux and treatments (17 papers) and Gastric Cancer Management and Outcomes (10 papers). Shu Sahara collaborates with scholars based in Japan, United States and Chile. Shu Sahara's co-authors include Takahisa Furuta, Mitsushige Sugimoto, Takahiro Uotani, Ken Sugimoto, Mihoko Yamade, Hiroaki Miyajima, Hitomi Ichikawa, Satoshi Osawa, Takuma Kagami and H. Ichikawa and has published in prestigious journals such as Gastroenterology, American Journal of Respiratory and Critical Care Medicine and World Journal of Gastroenterology.

In The Last Decade

Shu Sahara

42 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu Sahara Japan	15	771	463	376	162	71	45	881
Chise Kodaira Japan	18	639 0.8×	400 0.9×	231 0.6×	161 1.0×	40 0.6×	41	778
Takuma Kagami Japan	14	523 0.7×	347 0.7×	234 0.6×	110 0.7×	17 0.2×	33	639
Hitomi Ichikawa Japan	13	447 0.6×	248 0.5×	215 0.6×	83 0.5×	23 0.3×	42	513
Nobuo Funao Japan	8	542 0.7×	428 0.9×	226 0.6×	74 0.5×	13 0.2×	12	653
Tzung‐Jiun Tsai Taiwan	13	307 0.4×	126 0.3×	157 0.4×	54 0.3×	22 0.3×	37	508
Alain Farley Canada	14	690 0.9×	395 0.9×	174 0.5×	68 0.4×	20 0.3×	23	869
L. Lombardo Italy	13	390 0.5×	255 0.6×	104 0.3×	33 0.2×	40 0.6×	23	653
Sirikan Yamada Thailand	9	407 0.5×	52 0.1×	176 0.5×	51 0.3×	126 1.8×	18	519
Patrice A. Michaletz United States	11	516 0.7×	301 0.7×	166 0.4×	30 0.2×	28 0.4×	15	650
D. Graham United States	7	259 0.3×	108 0.2×	59 0.2×	24 0.1×	66 0.9×	18	480

Countries citing papers authored by Shu Sahara

Since Specialization

Citations

This map shows the geographic impact of Shu Sahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Sahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Sahara more than expected).

Fields of papers citing papers by Shu Sahara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Sahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Sahara. The network helps show where Shu Sahara may publish in the future.

Co-authorship network of co-authors of Shu Sahara

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Sahara. A scholar is included among the top collaborators of Shu Sahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Sahara. Shu Sahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makino, Hideki, et al.. (2025). A Case of CO2 Narcosis Caused by Aspergillus Tracheobronchitis During Treatment for Malignant Lymphoma. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7895–A7895.

Sahara, Shu, Mitsushige Sugimoto, Masaki Murata, et al.. (2024). Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review. Helicobacter. 29(3). e13106–e13106.

Ohashi, Naro, Mitsushige Sugimoto, Hitomi Ichikawa, et al.. (2018). Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients. Therapeutic Apheresis and Dialysis. 23(1). 65–72. 4 indexed citations

Sahara, Shu, Mitsushige Sugimoto, Hitomi Ichikawa, et al.. (2018). Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. Digestion. 97(2). 163–169. 3 indexed citations

Sugimoto, Mitsushige, Hiromitsu Ban, Hitomi Ichikawa, et al.. (2017). Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer. Internal Medicine. 56(6). 579–586. 92 indexed citations

Sugimoto, Mitsushige, Shu Sahara, Hitomi Ichikawa, et al.. (2017). Natural Course of <b><i>Helicobacter pylori</i></b> Infection in Japanese Hemodialysis Patients. Digestion. 95(4). 302–309. 5 indexed citations

Sakao, Yukinori, Mitsushige Sugimoto, Hitomi Ichikawa, et al.. (2016). Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients. American Journal of Nephrology. 44(3). 224–233. 7 indexed citations

Ichikawa, Hitomi, Mitsushige Sugimoto, Yukinori Sakao, et al.. (2016). Relationship between ghrelin,Helicobacter pyloriand gastric mucosal atrophy in hemodialysis patients. World Journal of Gastroenterology. 22(47). 10440–10440. 10 indexed citations

Furuta, Takahisa, Mitsushige Sugimoto, Chise Kodaira, et al.. (2016). Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel. Journal of Thrombosis and Thrombolysis. 43(3). 333–342. 14 indexed citations

10.

Sugimoto, Mitsushige, Shu Sahara, Hitomi Ichikawa, et al.. (2016). Four‐times‐daily Dosing of Rabeprazole with Sitafloxacin, High‐Dose Amoxicillin, or Both for Metronidazole‐Resistant Infection with Helicobacter pylori in Japan. Helicobacter. 22(1). 11 indexed citations

11.

Kagami, Takuma, Shu Sahara, H. Ichikawa, et al.. (2016). Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference toCYP2C19 genotype. Alimentary Pharmacology & Therapeutics. 43(10). 1048–1059. 187 indexed citations

12.

Sugimoto, Mitsushige, Shu Sahara, Hitomi Ichikawa, et al.. (2015). Mo1142 Efficacy of Surgical Spinal Correction in Patients With Severe Spinal Kyphotic Deformity for Gastroesophageal Reflux Disease and Bowel Habi. Gastroenterology. 148(4). S–619. 1 indexed citations

13.

Uotani, Takahiro, Mitsushige Sugimoto, Masafumi Nishino, et al.. (2014). Prevention of gastric mucosal injury induced by anti‐platelet drugs by famotidine. The Journal of Clinical Pharmacology. 54(8). 858–864. 3 indexed citations

14.

Sahara, Shu, Yoshiro Otsuki, Shinichi Shimizu, et al.. (2013). Primary synovial sarcoma of the stomach—A case report and review of the literature. Pathology - Research and Practice. 209(11). 745–750. 18 indexed citations

15.

Furuta, Takahisa, Yoshihiro Soya, Mitsushige Sugimoto, et al.. (2013). Rapid Automated Genotyping of CYP2C19 and Helicobacter pylori 23S rRNA Gene in Gastric Juice. Journal of Gastroenterology and Hepatology Research. 2(4). 508–512. 12 indexed citations

16.

Uotani, Takahiro, Mitsushige Sugimoto, Hitomi Ichikawa, et al.. (2013). Su1808 Comparison of Preventive Effects of Rabeprazole and Famotidine on Gastric Mucosal Injury Induced by Dual Therapy With Low-Dose Aspirin and Clopidogrel in Relation to CYP2C19 Genotypes and H. pylori Infection. Gastroenterology. 144(5). S–478. 1 indexed citations

17.

Yamade, Mihoko, Mitsushige Sugimoto, Masafumi Nishino, et al.. (2012). Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequence.. PubMed. 32(1). 105–14. 7 indexed citations

18.

Sugimoto, Mitsushige, Naohito Shirai, Masafumi Nishino, et al.. (2012). Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype. Alimentary Pharmacology & Therapeutics. 36(7). 627–634. 52 indexed citations

19.

Uotani, Takahiro, Mitsushige Sugimoto, Masafumi Nishino, et al.. (2012). Ability of Rabeprazole to Prevent Gastric Mucosal Damage From Clopidogrel and Low Doses of Aspirin Depends on CYP2C19 Genotype. Clinical Gastroenterology and Hepatology. 10(8). 879–885.e2. 22 indexed citations

20.

Ichinose, Izumi, Takeshi Nishioka, Masaharu Ishida, et al.. (1981). [Regeneration of gastric mucosal defect: especially differentiation of pseudopyloric gland (author's transl)].. PubMed. 78(5). 991–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact